Dr. Harry Heiman on Declining Trust in Federal Health Agencies and Drug Safety

Declining Trust in Federal Health Agencies

• 💡 Dr. Harry Heiman expresses concern that consumers can no longer rely on information from federal health agencies.
• 📌 This lack of trust is exemplified by the recent situation surrounding Tylenol use during pregnancy.

Tylenol Safety During Pregnancy

• ⚠️ President Trump's warning against Tylenol for pregnant women and children is contrasted with the FDA's more muted statement.
• 🔬 While some studies show a possible association between acetaminophen and autism, none have proven Tylenol to be a cause.
• 🤰 High fever during the first trimester of pregnancy is identified as a serious cause for congenital abnormalities and neurodevelopmental disabilities.
• 🩺 Dr. Heiman asserts that Tylenol remains the safest and most effective treatment for pain and fever during pregnancy, advising patients to rely on their physicians rather than federal agencies.

Politicization of Drug Safety and Review

• 🚀 The review of Mifepristone is questioned, with Dr. Heiman suggesting political drivers rather than new evidence are at play.
• ⚖️ He notes that this review is occurring in the context of legal actions by Republican attorneys general to restrict reproductive healthcare access.
• 📉 Dr. Heiman is disturbed by the deconstruction of federal public health agencies, such as the Division of Reproductive Health at the CDC, which are responsible for evaluating such medications.
• 🧩 The dismantling of expertise within health agencies is seen as more concerning than the review of a drug with 25 years of established safety and efficacy.